Central nervous system symptoms in a population of Behçet's disease patients with refractory uveitis treated with cyclosporine A

Clinical and Experimental Ophthalmology

Volumn 29, Issue 5, 2001, Pages 335-336

  Kato, Y ^a   Numaga, J ^a   Kato, S ^a   Kaburaki, T ^a   Kawashima, H ^a   Fujino, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; CORTICOSTEROID; CYCLOSPORIN A; PREDNISOLONE; STEROID;

ADULT; BEHCET DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; DYSKINESIA; EYE DISEASE; FEMALE; FEVER; HEADACHE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PATIENT MONITORING; PERSONALITY DISORDER; SPEECH DISORDER; TREATMENT FAILURE; TREMOR; UVEITIS;

ADOLESCENT; ADULT; BEHCET SYNDROME; BRAIN; BRAIN DISEASES; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; UVEITIS, ANTERIOR;

EID: 0034754892     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-9071.2001.00445.x     Document Type: Letter

References (7)

1. Treatment of intraocular inflammatory disease with cyclosporin A
2. Cyclosporin therapy in uveitis
3. Low dose cyclosporin treatment for ocular lesions of Behcet's disease
4. Clinical efficacy and side effects of low-dose cyclosporin A therapy in severe Behcet's disease
5. Cyclosporin-associated central nervous system toxicity after allogenic bone-marrow transplantation
6. Association between cyclosporin neurotoxicity and hypomagnesaemia
7. Central nervous system symptoms in patients with Behcet's disease receiving cyclosporine therapy